Zotarolimus alleviates post-trabeculectomy fibrosis via dual functions of anti-inflammation and regulating AMPK/mTOR axis DOI

Zhiruo Wang,

Gang Chen, Haoyu Li

et al.

International Immunopharmacology, Journal Year: 2024, Volume and Issue: 142, P. 113176 - 113176

Published: Sept. 20, 2024

Language: Английский

Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives DOI Creative Commons

Pei-Lun Xie,

Meng-Yu Zheng,

Ran Han

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: May 30, 2024

Traditionally, pharmacological mammalian/mechanistic targets of rapamycin (mTOR) kinase inhibitors have been used during transplantation and tumor treatment. Emerging pre-clinical evidence from the last decade displayed surprising effectiveness mTOR in ameliorating Alzheimer's Disease (AD), a common neurodegenerative disorder characterized by progressive cognitive function decline memory loss. Research shows activation as an early event AD development, inhibiting may promote resolution many hallmarks Alzheimer's. Aberrant protein aggregation, including amyloid-beta (Aβ) deposition tau filaments, defects, are reversed upon inhibition. A closer inspection highlighted temporal dependence hallmark-specific nature such beneficial effects. Time administration relative to disease progression, maintenance functional lysosomal system, could modulate its effectiveness. Moreover, inhibition also exerts distinct effects between neurons, glial cells, endothelial cells. Different properties produce different based on blood-brain barrier (BBB) entry capacities sites. This questions viable intervention strategy. In this review, we first summarize available their characteristics. We then comprehensively update discuss results resolve AD. Key pathologies discussed include Aβ deposition, tauopathies, aberrant neuroinflammation, neurovascular system breakdowns.

Language: Английский

Citations

5

Increased reactive astrocytes and NLRC4-mediated neuronal pyroptosis in advanced visual structures contralateral to the optic nerve crush eye in mice DOI
Deling Li, Qiyue Hu, Zongyi Zhan

et al.

Experimental Eye Research, Journal Year: 2025, Volume and Issue: 251, P. 110235 - 110235

Published: Jan. 9, 2025

Language: Английский

Citations

0

Neuroimmune crosstalk in chronic neuroinflammation: microglial interactions and immune modulation DOI Creative Commons

Ludmila Müller,

Svetlana Di Benedetto

Frontiers in Cellular Neuroscience, Journal Year: 2025, Volume and Issue: 19

Published: April 7, 2025

Neuroinflammation is a fundamental feature of many chronic neurodegenerative diseases, where it contributes to disease onset, progression, and severity. This persistent inflammatory state arises from the activation innate adaptive immune responses within central nervous system (CNS), orchestrated by complex interplay resident cells, infiltrating peripheral an array molecular mediators such as cytokines, chemokines, extracellular vesicles. Among CNS-resident microglia play role, exhibiting dynamic spectrum phenotypes ranging neuroprotective neurotoxic. In sustained microglial often leads amplification cascades, reinforcing pathogenic cycle immune-mediated damage. Intercellular communication inflamed CNS persistence progression neuroinflammation. Microglia engage in extensive crosstalk with astrocytes, neurons, oligodendrocytes, shaping both local systemic responses. These interactions influence key processes synaptic pruning, phagocytosis, blood-brain barrier integrity, cytokine-mediated signaling. Understanding mechanisms cell-cell signaling this context critical for identifying therapeutic strategies modulate response restore homeostasis. review explores players neuroinflammation, focus on role microglia, pathways underlying intercellular communication, potential approaches mitigate neuroinflammatory damage diseases.

Language: Английский

Citations

0

Rapamycin protects glucocorticoid-induced glaucoma model mice against trabecular meshwork fibrosis by suppressing mTORC1/2 signaling DOI
Yuning Song, Feifei Wang,

Hongdou Luo

et al.

European Journal of Pharmacology, Journal Year: 2025, Volume and Issue: 990, P. 177269 - 177269

Published: Jan. 11, 2025

Language: Английский

Citations

0

Autophagy increases the survival rate of Macrobrachium rosenbergiiin after Aeromonas hydrophila infection DOI
Pengfei Chu,

Qieqi Qian,

Yaoshuang Shen

et al.

Aquaculture, Journal Year: 2023, Volume and Issue: 575, P. 739758 - 739758

Published: June 13, 2023

Language: Английский

Citations

8

Implantation of biomimetic polydopamine nanocomposite scaffold promotes optic nerve regeneration through modulating inhibitory microenvironment DOI Creative Commons
Tonghe Pan,

Yate Huang,

Jinfei Wei

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Nov. 7, 2024

Abstract Optic nerve regeneration remains challenging worldwide due to the limited intrinsic regenerative capacity of retinal ganglion cells (RGCs) and inhibitory microenvironment. Oxidative stress, induced by excessive reactive oxygen species (ROS) following optic injury, is associated with prolonged neuroinflammation, resulting in a secondary injury RGCs impairment axon regeneration. Herein, we developed bionic nanocomposite scaffold (GA@PDA) immunoregulatory ability for enhanced The ice-templating method was employed fabricate biopolymer-based scaffolds directional porous structure, mimicking nerve, which effectively guided oriented growth neuronal cells. incorporation bioinspired polydopamine nanoparticles (PDA NPs) further confers excellent ROS scavenging ability, thereby modulating phenotype transformation microglia/macrophages from pro-inflammatory M1 anti-inflammatory M2. In rat crush model, implantation GA@PDA survival promoted axonal Our study offers novel insights holds promising potential advancement engineered biomaterials facilitating

Language: Английский

Citations

2

Tafluprost promotes axon regeneration after optic nerve crush via Zn2+-mTOR pathway DOI

Siting Wu,

Canying Liu, J. Tang

et al.

Neuropharmacology, Journal Year: 2023, Volume and Issue: 242, P. 109746 - 109746

Published: Oct. 12, 2023

Language: Английский

Citations

5

Therapeutic strategies for glaucoma and optic neuropathies DOI Creative Commons
Jung Lo,

Kamakshi Mehta,

Armaan Dhillon

et al.

Molecular Aspects of Medicine, Journal Year: 2023, Volume and Issue: 94, P. 101219 - 101219

Published: Oct. 13, 2023

Language: Английский

Citations

5

Cellular senescence mediates retinal ganglion cell survival regulation post‐optic nerve crush injury DOI Creative Commons
Yao Yao,

Xin Bin,

Yanxuan Xu

et al.

Cell Proliferation, Journal Year: 2024, Volume and Issue: 57(12)

Published: July 18, 2024

Traumatic optic neuropathy refers to nerve (ON) injury by trauma, including explosion and traffic accident. Retinal ganglion cell (RGC) death is the critical pathological cause of irreversible visual impairment blindness in ON injury. We previously investigated patterns 11 modes mouse retina post-ON Here we aimed identify additional signalling pathways regulating RGC survival rodents RNA sequencing analysis identified upregulation inflammation cellular senescence-related genes injury, which were confirmed immunoblotting immunofluorescence analyses. Increased expression senescence-associated β-galactosidase (SA-βgal) RGCs activation microglia also found. Transforming growth factor-β receptor type II inhibitor (LY2109761) treatment suppressed p15

Language: Английский

Citations

1

Reduced Zn2+ promotes retinal ganglion cells survival and optic nerve regeneration after injury through inhibiting autophagy mediated by ROS/Nrf2 DOI

Caiqing Wu,

Jiaxu Han,

Siting Wu

et al.

Free Radical Biology and Medicine, Journal Year: 2023, Volume and Issue: 212, P. 415 - 432

Published: Dec. 20, 2023

Language: Английский

Citations

3